{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-031242","form_type":"8-K","ticker":"INIS","cik":"0001038277","company_name":"RADNOSTIX INC","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.613207+00:00","generated_at":"2026-05-17T03:21:05.256734+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"International Isotopes enters CEO employment agreement, appoints Dr. Duke Fu as director, and amends bylaws","bullets":["CEO Shahe Bagerdjian signs new employment agreement with $314,000 base salary, 5% annual increases, and 37,500,000 RSUs vesting at share price milestones up to $0.30.","Dr. Duke W. Fu appointed to board and audit committee; receives 250,000 RSUs per annual term starting July 11, 2026.","Bylaws amended to add advance notice procedures for shareholder business and director nominations, and provisions for indemnification and insurance.","Bylaws now allow postponement of special meetings and shareholder action by less-than-unanimous written consent."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-031242","json":"https://secwatch.observer/filing/0001437749-25-031242.json","markdown":"https://secwatch.observer/filing/0001437749-25-031242.md","text":"https://secwatch.observer/filing/0001437749-25-031242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1038277/000143774925031242/0001437749-25-031242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1038277/000143774925031242/inis20251016_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T03:21:05.256734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"097dd567fcc24a4c65c030e69e372b57401b4748","claim":"RADNOSTIX INC: The Board approved amendments to the Company's bylaws, including revisions to special meetings, addition of advance notice procedures for business and nominations, addition of advisory directors, revision of shareholder written consent, and addition of indemnification and insurance provisions (effective 2025-10-14).","evidence_excerpt":"On October 14, 2025, the Board approved changes to the Company’s bylaws (the “Bylaws”), which are summarized below, and which are attached in full as an exhibit hereto.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1038277/000143774925031242/0001437749-25-031242-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-10-14"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}